Frequently Asked Questions:
COVID-19 has negatively impacted the market due to the outbreak of the COVID-19 pandemic, as all non-essential surgeries and healthcare procedures were postponed.
North America accounted for the most heightened share in the global subdermal contraceptive implants market.
The rising need for modern contraceptive methods, awareness about sexual health and family planning, and increasing government initiatives drive the subdermal contraceptive implants market.
The etonogestrel Implants segment had a major share in the global market in 2022.
The hospitals’ segment had a major share in the global market.